ALBERTDAVD vs DRREDDY: Stock Comparison

ALBERT DAVID vs DR. REDDY S LABORATORIESUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

DR. REDDY S LABORATORIES is the larger company by market capitalisation. ALBERT DAVID shows a lower P/E, faster revenue growth and lower leverage, while DR. REDDY S LABORATORIES shows a higher ROE, a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALBERTDAVD leads 7; DRREDDY leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALBERTDAVDDRREDDY

Valuation lens

What price are you paying?

Market CapContext only
₹493 Cr
₹96,322 Cr
P/E RatioALBERTDAVD has the lower reading
20.47x
30.07x
P/B RatioALBERTDAVD has the lower reading
1.18x
2.56x
EPSALBERTDAVD has the higher reading
₹56.07
₹5.32
Book ValueContext only
₹686.04
₹458.03
Dividend YieldDRREDDY has the higher reading
0.58%
0.69%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
DRREDDY is the larger company
₹96,322 Cr vs ₹493 Cr
P/E Ratio
ALBERTDAVD has a lower P/E
20.47x vs 30.07x
P/B Ratio
ALBERTDAVD has a lower P/B
1.18x vs 2.56x
EPS
ALBERTDAVD has higher earnings per share
₹56.07 vs ₹5.32
Dividend Yield
DRREDDY has a higher dividend yield
0.69% vs 0.58%
Revenue Growth (TTM YoY)
ALBERTDAVD has faster revenue growth
14.6% vs -11.6%
EPS Growth (TTM YoY)
ALBERTDAVD has faster EPS growth
0% vs -86.2%
Qtr Sales Growth
DRREDDY has stronger quarterly sales growth
57.69% vs -69.62%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDDRREDDY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDDRREDDY
Live Price₹860.25₹1,151
Day Change-1.14%-0.35%
Volume3,3395.68 L
52-Week High₹931.85₹1,414.9
52-Week Low₹579.9₹1,101
Distance from 52W High-7.68%-18.65%

Valuation

MetricALBERTDAVDDRREDDY
Market Cap₹493 Cr₹96,322 Cr
P/E Ratio20.47x30.07x
P/B Ratio1.18x2.56x
EPS₹56.07₹5.32
Book Value₹686.04₹458.03
Dividend Yield0.58%0.69%

Growth

MetricALBERTDAVDDRREDDY
Revenue Growth (TTM YoY)14.6%-11.6%
EPS Growth (TTM YoY)0%-86.2%
Qtr Sales Growth-69.62%57.69%
Qtr Profit Growth2,240.75%7.64%

Profitability & Leverage

MetricALBERTDAVDDRREDDY
ROE-0.38%10.87%
ROCE-2.14%10.31%
Net Margin-0.45%12.76%
Operating Margin0.95%17.07%
Debt to Equity0.07x0.16x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALBERTDAVDDRREDDY
Promoter Holding62.24%26.64% 0.01 pp
FII Holding0.57% 0.01 pp32.07% 1.01 pp
DII Holding1.64% 0.02 pp31.74% 1.02 pp
Public Holding35.56% 0.04 pp9.35% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALBERT DAVID and DR. REDDY S LABORATORIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.